Literature DB >> 25363850

Change in tear film characteristics in visual display terminal users.

Alper Yazici1, Esin S Sari, Gozde Sahin, Adil Kilic, Harun Cakmak, Orhan Ayar, Samet S Ermis.   

Abstract

PURPOSE: To evaluate changes in symptoms and tear film characteristics in young computer users.
METHODS: Fifty-one computer users and 26 controls were evaluated at the beginning and the end of the working day. Subjects with ocular or systemic disease, history of ocular surgery, use of contact lenses or glasses with antireflective surfaces, and use of topical or systemic medications were excluded from the study. Computer use duration, Ocular Surface Disease Index (OSDI) questionnaire, tear osmolarity, Schirmer test, tear break-up time (TBUT), and ocular surface vital dye staining were performed prevocationally and postvocationally.
RESULTS: The mean age was 31.2 ± 6.3 years in computer users and 33.7 ± 5.8 in controls. The mean reported computer use was 6.9 ± 2.7 hours/day in computer users and 0.4 ± 0.5 hours/day in controls. The mean prevocational and postvocational values in computer users for OSDI, osmolarity, TBUT, and Schirmer test were 23.2 ± 16.6 and 27.0 ± 17.6, 306.6 ± 14.9 and 311.0 ± 12.5 mOsm/L, 13.9 ± 4.0 and 13.2 ± 3.8 seconds, 22.7 ± 11.8 and 20.6 ± 12.5 mm, respectively. The vocational change was significant for all parameters in the computer user group but not in the control group. The osmolarity-based dry eye diagnosis was 27.4% in the computer users while it was 15.4% in the control group. Oxford score was only grade 1 in 5.9% of visual display terminal users and did not change at the end of the day.
CONCLUSIONS: Both symptoms and signs of dry eye increased significantly with computer use. Approximately 1 of every 3-4 computer users was found to have dry eye with higher tear osmolarity values.

Entities:  

Mesh:

Year:  2014        PMID: 25363850     DOI: 10.5301/ejo.5000525

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  12 in total

Review 1.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

2.  Ocular surface and tear film status among contact lens wearers and non-wearers who use VDT at work: comparing three different lens types.

Authors:  Ana Tauste; Elena Ronda; Valborg Baste; Magne Bråtveit; Bente E Moen; María-Del-Mar Seguí Crespo
Journal:  Int Arch Occup Environ Health       Date:  2017-12-04       Impact factor: 3.015

3.  Transient tear hyperosmolarity disrupts the neuroimmune homeostasis of the ocular surface and facilitates dry eye onset.

Authors:  Mauricio Guzmán; Maximiliano Miglio; Irene Keitelman; Carolina Maiumi Shiromizu; Florencia Sabbione; Federico Fuentes; Analía S Trevani; Mirta N Giordano; Jeremías G Galletti
Journal:  Immunology       Date:  2020-08-14       Impact factor: 7.397

4.  Prevalence of ocular surface disease symptoms and risk factors in group of university students in Monterrey, Mexico.

Authors:  Manuel Garza-León; Miguel Valencia-Garza; Bernardo Martínez-Leal; Pablo Villarreal-Peña; Hernán Gerardo Marcos-Abdala; Ana Lucía Cortéz-Guajardo; Arturo Jasso-Banda
Journal:  J Ophthalmic Inflamm Infect       Date:  2016-11-18

Review 5.  Use of the Controlled Adverse Environment (CAE) in Clinical Research: A Review.

Authors:  George W Ousler; David Rimmer; Lisa M Smith; Mark B Abelson
Journal:  Ophthalmol Ther       Date:  2017-09-27

6.  Investigation of Dry Eye Symptoms in Lecturers by Ocular Surface Disease Index

Authors:  Sümbüle Köksoy Vayısoğlu; Emine Öncü; Özer Dursun; Erdem Dinç
Journal:  Turk J Ophthalmol       Date:  2019-06-27

7.  Effect of warming eyelids on tear film stability and quality of life in visual display terminal users: a randomized controlled trial.

Authors:  Chi-Chin Sun; Chia-Yi Lee; Yih-Shiou Hwang; Igaki Michihito; Kyoko Tagami; Ching-Hsi Hsiao
Journal:  Sci Rep       Date:  2020-10-09       Impact factor: 4.379

Review 8.  Practical Guidance for the Use of Loteprednol Etabonate Ophthalmic Suspension 0.25% in the Management of Dry Eye Disease.

Authors:  Nandini Venkateswaran; Yandong Bian; Preeya K Gupta
Journal:  Clin Ophthalmol       Date:  2022-02-09

Review 9.  Prevalence of dry eye disease in visual display terminal workers: a systematic review and meta-analysis.

Authors:  Romain Courtin; Bruno Pereira; Geraldine Naughton; Alain Chamoux; Frédéric Chiambaretta; Charlotte Lanhers; Frédéric Dutheil
Journal:  BMJ Open       Date:  2016-01-14       Impact factor: 2.692

10.  Commercially Available Eye Drops Containing Trehalose Protect Against Dry Conditions via Autophagy Induction.

Authors:  Eva Hernandez; Clémence Taisne; Marion Lussignol; Audrey Esclatine; Marc Labetoulle
Journal:  J Ocul Pharmacol Ther       Date:  2021-07-06       Impact factor: 2.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.